Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC888626881;26882;26883 chr2:178714002;178714001;178714000chr2:179578729;179578728;179578727
N2AB856925930;25931;25932 chr2:178714002;178714001;178714000chr2:179578729;179578728;179578727
N2A764223149;23150;23151 chr2:178714002;178714001;178714000chr2:179578729;179578728;179578727
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Ig-74
  • Domain position: 57
  • Structural Position: 137
  • Q(SASA): 0.1332
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 0.801 N 0.683 0.299 0.261217442401 gnomAD-4.0.0 2.40069E-06 None None None None N None 0 0 None 0 0 None 0 0 2.62506E-06 0 0
G/S rs72648991 -1.142 0.233 N 0.269 0.188 0.156986980423 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.88E-06 0
G/S rs72648991 -1.142 0.233 N 0.269 0.188 0.156986980423 gnomAD-4.0.0 2.2582E-05 None None None None N None 0 0 None 0 0 None 0 1.7337E-04 2.69863E-05 1.1598E-05 1.65711E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.0871 likely_benign 0.0931 benign -0.519 Destabilizing 0.454 N 0.544 neutral N 0.444976413 None None N
G/C 0.1408 likely_benign 0.1542 benign -0.958 Destabilizing 0.145 N 0.665 neutral N 0.486228389 None None N
G/D 0.4367 ambiguous 0.5001 ambiguous -1.491 Destabilizing 0.801 D 0.683 prob.neutral N 0.440109311 None None N
G/E 0.3044 likely_benign 0.3545 ambiguous -1.359 Destabilizing 0.842 D 0.684 prob.neutral None None None None N
G/F 0.4554 ambiguous 0.4968 ambiguous -0.575 Destabilizing 0.037 N 0.664 neutral None None None None N
G/H 0.3675 ambiguous 0.4015 ambiguous -1.655 Destabilizing 0.998 D 0.662 neutral None None None None N
G/I 0.1698 likely_benign 0.1934 benign 0.483 Stabilizing 0.949 D 0.686 prob.neutral None None None None N
G/K 0.4696 ambiguous 0.5247 ambiguous -0.838 Destabilizing 0.842 D 0.683 prob.neutral None None None None N
G/L 0.2785 likely_benign 0.3113 benign 0.483 Stabilizing 0.728 D 0.703 prob.neutral None None None None N
G/M 0.3064 likely_benign 0.3347 benign 0.134 Stabilizing 0.998 D 0.701 prob.neutral None None None None N
G/N 0.3136 likely_benign 0.3439 ambiguous -0.947 Destabilizing 0.842 D 0.655 neutral None None None None N
G/P 0.9672 likely_pathogenic 0.9734 pathogenic 0.195 Stabilizing 0.974 D 0.673 neutral None None None None N
G/Q 0.3202 likely_benign 0.3623 ambiguous -0.814 Destabilizing 0.974 D 0.68 prob.neutral None None None None N
G/R 0.3183 likely_benign 0.3629 ambiguous -1.024 Destabilizing 0.986 D 0.68 prob.neutral N 0.433047265 None None N
G/S 0.0782 likely_benign 0.0824 benign -1.332 Destabilizing 0.233 N 0.269 neutral N 0.353103615 None None N
G/T 0.1 likely_benign 0.1034 benign -1.075 Destabilizing 0.067 N 0.497 neutral None None None None N
G/V 0.1248 likely_benign 0.1441 benign 0.195 Stabilizing 0.669 D 0.707 prob.neutral N 0.419368679 None None N
G/W 0.3834 ambiguous 0.4342 ambiguous -1.31 Destabilizing 0.998 D 0.675 prob.neutral None None None None N
G/Y 0.3518 ambiguous 0.4138 ambiguous -0.679 Destabilizing 0.904 D 0.705 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.